16-1219006-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.5924C>T​(p.Ser1975Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000202 in 1,550,324 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1975S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00075 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.902

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018131495).
BP6
Variant 16-1219006-C-T is Benign according to our data. Variant chr16-1219006-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 460156.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000749 (114/152298) while in subpopulation AFR AF = 0.00255 (106/41556). AF 95% confidence interval is 0.00216. There are 0 homozygotes in GnomAd4. There are 56 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 114 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5924C>T p.Ser1975Phe missense_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5924C>T p.Ser1975Phe missense_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5939C>T p.Ser1980Phe missense_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5909C>T p.Ser1970Phe missense_variant Exon 33 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5906C>T p.Ser1969Phe missense_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5906C>T p.Ser1969Phe missense_variant Exon 34 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5891C>T p.Ser1964Phe missense_variant Exon 34 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5885C>T p.Ser1962Phe missense_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5873C>T p.Ser1958Phe missense_variant Exon 33 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5867C>T p.Ser1956Phe missense_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5924C>T p.Ser1975Phe missense_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5873C>T p.Ser1958Phe missense_variant Exon 33 of 35 ENSP00000518774.1
CACNA1HENST00000711483.1 linkc.5924C>T p.Ser1975Phe missense_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.5924C>T non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1843C>T non_coding_transcript_exon_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*972C>T non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3742C>T non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5368C>T non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*865C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*783C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1503C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*591C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*558C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5873C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5924C>T non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5891C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1040C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1843C>T 3_prime_UTR_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*972C>T 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3742C>T 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5368C>T 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*865C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*783C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1503C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*591C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*558C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*1040C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711455.1 linkc.5888-42C>T intron_variant Intron 33 of 35 ENSP00000518768.1
CACNA1HENST00000711456.1 linkc.5887+355C>T intron_variant Intron 33 of 33 ENSP00000518769.1

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152180
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000168
AC:
26
AN:
154606
AF XY:
0.000170
show subpopulations
Gnomad AFR exome
AF:
0.00270
Gnomad AMR exome
AF:
0.0000406
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000672
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000142
AC:
199
AN:
1398026
Hom.:
1
Cov.:
33
AF XY:
0.000116
AC XY:
80
AN XY:
689542
show subpopulations
African (AFR)
AF:
0.00301
AC:
95
AN:
31596
American (AMR)
AF:
0.0000280
AC:
1
AN:
35694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25164
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35736
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48050
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5680
European-Non Finnish (NFE)
AF:
0.0000834
AC:
90
AN:
1078882
Other (OTH)
AF:
0.000190
AC:
11
AN:
57994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000749
AC:
114
AN:
152298
Hom.:
0
Cov.:
31
AF XY:
0.000752
AC XY:
56
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00255
AC:
106
AN:
41556
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68026
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000579
Hom.:
0
Bravo
AF:
0.000922
ESP6500AA
AF:
0.00233
AC:
8
ESP6500EA
AF:
0.000147
AC:
1
ExAC
AF:
0.000185
AC:
8

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 14, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5924C>T (p.S1975F) alteration is located in exon 34 (coding exon 33) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 5924, causing the serine (S) at amino acid position 1975 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 01, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;.;.;.
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.77
T;T;T;.
M_CAP
Pathogenic
0.42
D
MetaRNN
Benign
0.018
T;T;T;T
MetaSVM
Uncertain
0.32
D
MutationAssessor
Benign
1.2
L;.;.;.
PhyloP100
0.90
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.6
D;.;D;D
REVEL
Uncertain
0.35
Sift
Benign
0.11
T;.;T;T
Sift4G
Benign
0.15
T;.;T;T
Polyphen
0.68
P;.;P;P
Vest4
0.22
MVP
0.93
ClinPred
0.065
T
GERP RS
3.5
Varity_R
0.15
gMVP
0.30
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186422070; hg19: chr16-1269006; API